IDiyas

For the Inventor, By the Inventor

Cranbury, NJ, United States of America

Krishnaswamy Srinivas Raghavan

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 118(Granted Patents)


Company Filing History:

goldMedal10 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents

Years Active: 2001-2014

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 8632788 - Parenteral formulation for epothilone analogs (2014-01-21),
2. 8252821 - Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound (2012-08-28),
3. RE40387 - Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones (2008-06-16),
4. 7053069 - Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives (2006-05-30),
5. 7022330 - Parenteral formulation for epothilone analogs (2006-04-04),
6. 6670384 - Methods of administering epothilone analogs for the treatment of cancer (2003-12-30),
7. 6589955 - Pediatric formulation of gatifloxacin (2003-07-08),
8. 6576651 - Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones (2003-06-10),
9. 6413969 - Gatifloxacin pentahydrate (2002-07-02),
10. 6218375 - Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-&bgr;-cyclodextrin or 2-hydroxypropyl-&bgr;-cyclodextrin and method (2001-04-17),

Title: Innovations of Krishnaswamy Srinivas Raghavan

Introduction

Krishnaswamy Srinivas Raghavan is a notable inventor based in Cranbury, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work focuses on innovative formulations that enhance the delivery and efficacy of therapeutic compounds.

Latest Patents

Among his latest patents is a parenteral formulation for epothilone analogs. This process involves dissolving the analog in a mixture of at least 50% by volume tertiary-butanol in water, followed by lyophilization. The resulting product is packaged in a vial with a solvent comprising anhydrous ethanol and a suitable nonionic surfactant. In practice, the contents of the diluent vial are added to the lyophilized product to create a solution for intravenous injection. Another significant patent is for bioavailable capsule compositions of an amorphous alpha-(N-sulfonamido)acetamide compound. This composition includes various excipients such as polyethylene glycol and Vitamin E polyethylene glycol succinate, aimed at improving the bioavailability of the active compound.

Career Highlights

Krishnaswamy Srinivas Raghavan is currently associated with Bristol-Myers Squibb Company, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing formulations that address critical medical needs.

Collaborations

He has collaborated with notable colleagues, including Timothy M Malloy and Sailesh A Varia, contributing to a dynamic research environment that fosters innovation.

Conclusion

Krishnaswamy Srinivas Raghavan's contributions to pharmaceutical formulations exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to improving patient care through advanced drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…